Study A - MK0767 Monotherapy Study

Summary

The purpose of this study is to test if MK0767 lowers blood glucose after 20 weeks compared to placebo. This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).

Timeline

Start

2003-02

Primary completion

2003-11

Completion

2003-11

Drugs

Indications